Blue Horseshoe Stocks: BLNK, Bottom-Play & More

Blink Charging Co. BLNK

We signaled our interest in BLNK in yesterday morning’s premarket report via the Extended Watchlist, and we’re happy to report on what was a very productive first day of observation.

From a low of 4.34, BLNK made a highly respectable intraday run to 6.34, marking an intraday push of 46% Prior to Monday’s session, wherein the stock picked up in a big way, it had been trading sideways for quite some time. We will be interested in monitoring this play for the possibility of a more sustained uptrend in the days ahead.


Gogo. Inc. GOGO

We want to also bring some attention to the massive selloff which has occurred over the past three trading days. After trading for nearly $10/share, a disappointing earnings release and subsequent Moody’s downgrade has precipitated close to a 50% drop, leaving GOGO trading at just above $5.

We’re going to want to put this one on intensive bottom-watch, as we prepare for possible course correction leading to a bounce play opportunity.


Fresh Options Idea:
Trip Advisor, Inc. TRIP Weekly $45.50 & $46 Calls


Extended Watchlist:
UURAF, TRXC, PLUG, LC, MNKD, GRPN, ICHR, TWLO

Blue Horseshoe Stocks: Reviewing June Winners & More

Moleculin Biotech,  Inc. MBRX

We wanted to circle back for an update on MBRX this morning, a stock that we signaled on June 21st, after noticing some abnormal activity the session prior.

Shortly thereafter we would witness a low of .96 in the stock, from which it would never look back. MBRX has been on a multi-day tear, with things really heating up yesterday. It ripped its way to a new high of 3.38, on more than 16 times the monthly average volume. That represents a total rise of 252%

We’ll continue to stay hot on the trail of MBRX for as long as it continues to build higher base levels of support.



Spherix Corp. SPEX

The day before the above-mentioned play, on June 20th, we highlighted SPEX after noticing the stock trading near a bottom, and it has been one heck of a ride since that time. We’ve seen this play run from a low of .9505 all the way up to 2.23.

The bulk of that move came in yesterday’s session wherein the stock also traded massive volume, so we’ll be on the lookout for a possible momentum spillover as we head into week’s end.


TrovaGene Inc. TROV

It was back on June 12th that we initially slated TROV for observation. The stock had been trending up off of recent relative lows since the beginning of this month.

Subsequent to our alert, we would witness a low of .85 in the stock and despite some swing-action, TROV has been in a general uptrend ever since.. As of the new high achieved in this morning’s premarket (1.60) it marks an increase of 88%


Constellation Brands, Inc. STZ – Options Idea

We’ve used the STZ optuions chain to our advantage in the past. The most recent occasion was last April, when we scored multibag gains with $155 Calls. The stock has been in serious growth-mode since then, and with a hearty, untraded-upon Q1 earnings beat this morning, we want to signal a range of contracts to watch once again.

The stock is gapping up to the $200-range today, and we’re going to be waiting in the wings with the STZ 07/21 $190-210 Calls.


Extended Watchlist:
GRPN, CHFS, SPLS, IMNP, LODE, INNMF

Blue Horseshoe Stocks: MNKD, VRX Recaps & More

MannKind Corp. MNKD

We tagged MNKD a week ago today in our premarket report on May 4th, and wanted to circle back around this morning to go over the excellent performance the stock has recorded since then. At the time the stock had been looking like it wanted to rebound after crashing down to a bottom and our decision to mention it turned out to be timed perfectly.

In each of the past five sessions MNKD has registered higher highs and higher lows, continuing to gain back ground that it had lost in previous weeks. From last Thursday’s low of .688, the stock has gone on to reach a high of 1.88, which represents an increase of 173% while volume over the same period has been impressive. The stock traded its highest volume since 2014 yesterday, so we’re really eager to continue tracking the activity in MNKD.


Valeant Pharmaceuticals, Inc. VRX

Despite already showing us amazing single-session gains ranging from 380-3600% on Tuesday, which we recapped in yesterday’s premarket report, our options idea for the VRX chain, the Weekly $10.50-12 Calls saw even further advances once the session kicked off.

We’ve included the total possible intraday gains from yesterday’s session, as well as the overall gains from our observed lows on Tuesday morning.

$10.50 Calls
– Daily Range: 1.43-2.36 – Daily Gain: 65% – Total Range: .40-2.36 – Two-Day Swing: 490%
$11 Calls – Daily Range: .92-1.99 – Daily Gain: 116% – Total Range: .18-1.99 – Two-Day Swing: 1005%
$11.50 Calls – Daily Range: .53-1.42 – Daily Gain: 68% – Total Range: .08-1.42 – Two-Day Swing: 1675%
$12 Calls – Daily Range: .29-.99 – Daily Gain: 241% – Total Range: .02-.99 – Two-Day Swing: 4850%

Even though it’s not even close to our only percentage gainer in the thousands, this round of options calls with VRX is certainly going down as one of our most solid picks of the year so far. Even if someone had only bought shares in VRX stock itself, they could have been up just over 22% on this two-day swing.


Groupon, Inc. GRPN

We want to place GRPN on recovery watch after noticing the stock coming up off a double-bottom, with a gap on the chart to fill to the upside, as you can see on the included snapshot.

We like to monitor plays in this position, so we’ll put it on our radars in the days and weeks ahead. Given the look of this chart, we’d classify this as relatively low-risk, low-reward in comparison one of our average plays.


Extended Watchlist:
DEST, LPSN, MSLI, SGMO, SYN, SYMX

Blue Horseshoe Stocks: Options Update, GALT Recap & More

Whole Foods Market, Inc. WFM – Options Update

We just wanted to circle back for our WFM options idea that we submitted last week. We designated contracts with a 02/17 expiration instead of weeklies to give our idea time to develop and it ended up being a good call. Our targets were the WFM 02/17 $30 and 30.50 Calls.

Yesterday WFM had a morning pullback which was followed by a nice reversal, and the stock ended up bulling its way into the close near its high of day. The calls we signaled last week had a significant move as a result. The $30 Calls ran from .14-.52 (+271%), while the $30.50′s exploded from .05-.21 (+320%). We are going to want to keep them on our radar for the rest of the week into expiration.

Key resistance is at the 200DMA and 50DMA of 30.38 and 30.76, respectively. If WFM can crack the latter, we may look to roll our strike price up and push out another week to contracts expiring next Friday- particularly, the WFM 02/24 $31 Calls.



Galectin Therapeutics, Inc. GALT

We’ve now witnessed quite a run from GALT over the past few weeks, validating our previous reports on the stock wherein we contested that a serious run-up appeared likely.

It began with our report on 01/12, in which we noted GALT’s ripening chart, and surmised that forthcoming gains of 100% were not out of the question. We observed a low of .935 subsequent to that followed by a nice 38% push to 1.29 leading into our most recent report on GALT last Friday.

In that report we had this to say “We feel these gains are sustainable if GALT can manage to crack past the current 200DMA at 1.32. As you can see on the included snapshot, the chart continues to bear the look of potential for even further increases“.

Yesterday GALT met those expectations nicely with a run to a new high of 1.85, which marks an overall increase from our observed low of 98%, falling just a hair shy of our initial speculations. Yet, our prediction seems to be coming full circle this morning as the stock is gearing up to fill its gap on the chart that we pointed out in our initial report. One more bullish push will get us into double-bagger territory for this idea, and the stock may well make a run well into the 2.00-range.


Green EnviroTech Holdings Corp. GETH – Recap

We were quite pleased with the performance of GETH following our featured report yesterday morning, as the stock provided traders with a pair of solid intraday swings amid an onslaught of volume.

Right from the opening bell, GETH shot up from .165 to the high of day at .235, marking an initial rip of 42% The stock subsequently pulled back to a daily low at .1514, before surging up once more to .215, matching the morning’s 42% gain exactly.

All of this useful volatility was accompanied by massive volume on the order of 39X the monthly average, or 19X the 3-month average. It represented an all-time record high for shares of GETH traded in a single session!

Yesterday we had identified .15 as the key support level that needed to hold in order to make GETH interesting, and our sentiments in that regard haven’t changed.


Extended Watchlist:
ONOV, GAHC, NNSR, BG, WIX, GRPN, EVOK,

Blue Horseshoe Stocks: BTCS Recap, EVOK & More

BTCS, Inc. BTCS

We caught BTCS on a routine scan yesterday morning after noticing some abnormal activity from the session prior. Our timing ended up being extremely fortuitous, with the stock making quite an impressive morning run.

From a low of .0013, it surged up as high as .0024 just prior to midday, for a healthy pop of 85% on almost ten times the three-month average volume. If BTCS can hold support at or above yesterday’s swing low, we’ll continue to be interested in the possibilities it may provide.


Evoke Pharma, Inc. EVOK

EVOK is another fresh play that we’re taking a look at for the first time this morning. The stock has recently fallen off of a cliff, as we’ve pointed out on the annotated chart below. Beginning with a massive gap-down earlier this month, followed by several sessions of backsliding which culminated in a new 52-week low (1.52) being set on Monday.

Yesterday’s bottom-bounce activity is what has us on alert. The stock is heavily oversold, and could be in line for a substantial rebound. We’ll want to be hanging around when that occurs, because even a return to the bottom of the chart gap at 3.50, from current levels, would spell an opportunity for significant gains.


Tempur Sealy International, Inc. TPX – Options Idea

TPX is fresh off an earnings beat this morning which has it gapping up into the $70-range. We’re going to signal a range of longer-term options ideas for us to track in the days and weeks to come. Our area of interest here is going to be the TPX 08/19 $70-80 Calls, giving us just over three weeks’ time to see a continued PPS recovery. 


Extended Watchlist:
SOULD, GYST, GRPN, EBIO, EPRS, WEYL
 NSRS(Potential Bottom Bouncer)